市场调查报告书
商品编码
1608717
脸部回春市场:依产品类型、最终用户、地区Facial Rejuvenation Market, By Product Type (Topical Rejuvenation Products and Equipment ), By End User, By Geography |
预计2024年脸部回春市场规模将达281.4亿美元,2024年至2031年复合年增长率为7.9%,2031年将达到478.8亿美元。
分析范围 | 分析详情 | ||
---|---|---|---|
基准年 | 2023年 | 市场规模(2024年) | 281.4亿美元 |
实际资料 | 2019-2023 | 预测期 | 2024-2031 |
预测期复合年增长率(2024-2031): | 7.90% | 预计金额(2031年) | 478.8亿美元 |
由于对恢復青春的美容手术的需求不断增加,全球脸部回春市场正在稳步增长。脸部回春疗程有助于减少皮肤下垂、细纹和皱纹,并恢復脸部丰盈度和丰满度。人们越来越喜欢非侵入性治疗而不是手术方法,加上技术先进的产品和治疗方法的出现,可以推动市场成长。然而,整容手术的高成本可能会阻碍这种治疗的广泛使用。新兴经济体的美容意识和治疗接受度正在大幅增长,这将在预测期内开闢新的成长途径。
微创治疗的日益普及、可支配收入的增加、容易受到与老龄化相关的面部变化的老年人口的增加以及新兴国家医疗旅游业的快速增长正在推动市场的发展。然而,整容手术的高成本和缺乏报销政策可能会阻碍市场扩张。雷射表面置换、神经调节剂和真皮填充剂等新技术和设备的引入使得复杂病例的治疗成为可能,并开闢了新的机会。製造商正在积极投资研发,以开发副作用较少的更好产品。
本报告的主要特点
该报告对全球脸部回春市场进行了详细分析,估计了以2023年为基准年的预测期(2024-2031年)的市场规模(十亿美元)和年复合成长率(CAGR,%)。
它还揭示了各个细分市场的潜在商机,并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
我们根据以下参数对全球脸部回春市场的主要企业进行了分析:公司亮点、产品系列、主要亮点、财务表现、策略等。
本报告涵盖的主要企业包括 Merz Pharma、Anika Therapeutics、Lumenis、Galderma、AbbVie、Contura Ltd、Fibrocell Science、Revance Therapeutics、Cynosure、Alma Lasers 和 STRATA Skin Sciences、Sciton、Elevai Labs 和 SkinBioTherapeutics。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球脸部回春市场报告针对该行业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
Facial rejuvenation market is estimated to be valued at USD 28.14 Bn in 2024 and is expected to reach USD 47.88 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | 28.14 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 7.90% | 2031 Value Projection: | 47.88 Bn |
Global facial rejuvenation market has been witnessing steady growth, owing to rising demand for aesthetic procedures among people to restore youthful appearance. Facial rejuvenation treatments help reduce sagging skin, fine lines, wrinkles and restore volume and fullness to face. Growing preference for non-invasive procedures over surgical methods along with availability of technologically advanced products and treatments can drive the market growth. However, high cost of aesthetic procedures can hamper the widespread adoption of this treatment. Aesthetic awareness and acceptance of cosmetic treatments have increased considerably in emerging economies, thus, offering new avenues of growth over the forecast period.
Rising popularity of minimally invasive treatments, increasing disposable incomes, growing geriatric population susceptible to age-related facial changes and surge in medical tourism in developing nations can drive the market growth. However, high costs associated with aesthetic procedures and lack of reimbursement policies can hamper the market expansion. Introduction of novel technologies and equipment like laser resurfacing, neuromodulators and dermal fillers have opened new opportunities, enabling treatment of complex cases. Manufacturers are actively investing in R&D to develop superior products with reduced adverse effects.
Key features of the study
This report provides in-depth analysis of the global facial rejuvenation market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global facial rejuvenation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merz Pharma, Anika Therapeutics, Lumenis, Galderma, AbbVie, Contura Ltd, Fibrocell ScienceInc., Revance Therapeutics, Cynosure, Alma Lasers, STRATA Skin Sciences, Sciton, Inc., Elevai Labs, Inc., and SkinBioTherapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global facial rejuvenation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts